Prosecution Insights
Prosecution Insights
Technology area: Biotechnology & Pharmaceuticals
3 pending office actions • 2 art units • 3 examiners • 0 of 3 (0%) have an AI response strategy ready • 5 patents granted in the last 365 days
Glycom A/S manages 3 pending office actions in the Biotechnology & Pharmaceuticals technology area. While there are 3 distinct examiners involved, these actions are concentrated within 2 distinct art units. The busiest examiner for the portfolio is WHITE, ASHLEY TAYLOR, who is responsible for 1 pending office action. This structure shows that while there are 3 examiners, the technical focus remains within 2 specific art units.
The concentration of 3 pending office actions within 2 art units suggests that the company is pursuing related technologies within the Biotechnology & Pharmaceuticals field. This allows the legal team to potentially leverage insights from one art unit across multiple applications. The involvement of WHITE, ASHLEY TAYLOR as the busiest examiner with 1 pending office action indicates a distributed workload among the examiners. Managing 3 distinct examiners requires a coordinated effort to ensure that prosecution strategies are aligned. The focus on 2 art units may provide a more predictable examination environment than a more widely dispersed portfolio. Practitioners should monitor the Biotechnology & Pharmaceuticals sector trends that impact these specific units.
Based on the USPTO statutory response window for each pending office action. 2 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 3 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| WHITE, ASHLEY TAYLOR | 1 | 25.0% | +46.7% |
| KOROTCHKINA, LIOUBOV G | 1 | 29.5% | +67.7% |
| REGA, KYLE THOMAS | 1 | 62.7% | +41.4% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17754400 | SEPARATION OF NEUTRAL OLIGOSACCHARIDES FROM FERMENTATION BROTH | KOROTCHKINA, LIOUBOV G | 8d overdue |
| 18262099 | NEW MAJOR FACILITATOR SUPERFAMILY (MFS) PROTEIN (FRED) IN PRODUCTION OF SIALYLATED HMOS | WHITE, ASHLEY TAYLOR | 15d |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 3 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17754400 | SEPARATION OF NEUTRAL OLIGOSACCHARIDES FROM FERMENTATION BROTH | KOROTCHKINA, LIOUBOV G | 8d overdue |
| 18262099 | NEW MAJOR FACILITATOR SUPERFAMILY (MFS) PROTEIN (FRED) IN PRODUCTION OF SIALYLATED HMOS | WHITE, ASHLEY TAYLOR | 15d |
| 17299583 | SYNTHESIS OF THE FUCOSYLATED OLIGOSACCHARIDE LNFP-V | REGA, KYLE THOMAS | — |
| Art Unit | Apps |
|---|---|
| 1653 | 2 |
| 1636 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18262099 | NEW MAJOR FACILITATOR SUPERFAMILY (MFS) PROTEIN (FRED) IN PRODUCTION OF SIALYLATED HMOS | WHITE, ASHLEY TAYLOR | 1653 | §103 | Final Rejection | 15d | Pending | Jul 19, 2023 |
| 17754400 | SEPARATION OF NEUTRAL OLIGOSACCHARIDES FROM FERMENTATION BROTH | KOROTCHKINA, LIOUBOV G | 1653 | §103 | Final Rejection | 8d overdue | Pending | Mar 31, 2022 |
| 17299583 | SYNTHESIS OF THE FUCOSYLATED OLIGOSACCHARIDE LNFP-V | REGA, KYLE THOMAS | 1636 | §103 | Final Rejection | — | Pending | Jun 03, 2021 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial